Isabel Diebold; Talija Djordjevic; John Hess; Agnes Görlach
Experimentelle Kinderkardiologie, Deutsches Herzzentrum München an der Technischen Universität München, Munich, Germany
Pulmonary vascular remodeling is commonly associated with pulmonary hypertension and is characterized by media thickening and disordered cellular proliferation, often accompanied by fibrin deposition and thrombosis in situ. However, the signaling pathways linking these different processes are not well understood. Since the GTPase Rac-1 has been suggested to act as a signaling relay in various cell types we investigated whether Rac-1 could be the link between thrombin signaling,plasminogen activator inhibitor-1 (PAI-1), which inhibits fibrinolysis and promotes fibrin deposition, and proliferation of pulmonary artery smooth muscle cells (PASMC). Exposure to thrombin enhanced the levels of Rac-1 protein and increased PAI-1 mRNA and protein expression in dependence of the thrombin receptor PAR-1. Expression of dominant-negative Rac-1 (RacT17N) prevented thrombin-induced PAI-1 expression whereas constitutively active RacG12V enhanced PAI-1 levels. In the presence of RacT17N thrombin-induced PAI-1 promoter activity was abrogated whereas RacG12V increased PAI-1 promoter activity, and this response was essentially dependent on the transcription factor hypoxia-inducible factor-1 (HIF-1). Subsequently, RacG12V not only increased HIF transcriptional activity but also HIF-1α protein and mRNA levels, whereas RacT17N prevented these responses elicited by thrombin.In line,RacG12V enhanced HIF-1α promoter activity, and this response was dependent on nuclear factor-kappaB (NFκB) binding to the HIF-1α promoter. Finally, upregulation of PAI-1 by Rac-1 and HIF-1 was essential for thrombin-stimulated proliferation of PASMC.These findings indicate that Rac-1 is an important mediator of thrombin signaling and may contribute to pulmonary vascular remodeling via HIF-1-dependent upregulation of PAI-1 leading to enhanced proliferation of PASMC.
thrombin, smooth muscle cells, plasminogen activator inhibitor-1, PAR-1, Rac-1, hypoxia- inducible factor-1, pulmonary vascular remodeling
Frank Gieseler1, Inke Lühr2, Thomas Kunze2, Christoph Mundhenke1, Nicolai Maass1, Tobias Erhart2, Momme Denker2, Dennis Beckmann1, Markus Tiemann3, Christoph Schulte3, Peter Dohrmann1, Françoise Cavaillé4, François Godeau4, Christian Gespach5
Thromb Haemost 2007 97 6: 1023-1030
G. Nowak1, M. Lopez2, M. Zieger1
Hämostaseologie 2007 27 2: 105-110
Benjamin Richard, Marie-Christine Bouton, Stéphane Loyau, Damien Lavigne, Didier Letourneur, Martine Jandrot-Perrus, Véronique Arocas
Thromb Haemost 2006 95 2: 229-235
Patients receiving oral anticoagulants should be carefully managed to minimize the risk of bleeding...
Acquired haemophilia A (AHA) is a rare but often severe bleeding disorder caused by ...
Section III " Vitamin K antagonists in heart disease: Current status and perspectives" of...